<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407943</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The SpO<sub>2</sub>/FiO<sub>2</sub> Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5884</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195884</ELocationID><Abstract><AbstractText><b>Background:</b> Identifying high-risk COVID-19 patients is critical for emergency department decision-making. Our study's primary objective was to identify new independent predictors of mortality and their predictive utility in combination with traditional pneumonia risk assessment scores and new risk scores for COVID-19 developed during the pandemic. <b>Methods</b>: A retrospective study was performed in two Italian University Hospitals. A multivariable logistic model was used to locate independent parameters associated with mortality. <b>Results:</b> Age, PaO<sub>2</sub>/FiO<sub>2</sub>, and SpO<sub>2</sub>/FiO<sub>2</sub> ratios were found to be independent parameters associated with mortality. This study found that the Pneumonia Severity Index (PSI) was superior to many of the risk scores developed during the pandemic, for example, the International Severe Acute Respiratory Infection Consortium Coronavirus Clinical Characterisation Consortium (ISARIC 4C) (AUC 0.845 vs. 0.687, <i>p</i> &lt; 0.001), and to many of the risk scores already in use, for example, the National Early Warning Score 2 (NEWS2) (AUC 0.845 vs. 0.589, <i>p</i> &lt; 0.001). Furthermore, our study found that the Pneumonia Severity Index had a similar performance to other risk scores, such as CRB-65 (AUC 0.845 vs. 0.823, <i>p</i> = 0.294). Combining the PaO<sub>2</sub>/FiO<sub>2</sub> or SpO<sub>2</sub>/FiO<sub>2</sub> ratios with the risk scores analyzed improved the prognostic accuracy. <b>Conclusions:</b> Adding the SpO<sub>2</sub>/FiO<sub>2</sub> ratio to the traditional, validated, and already internationally known pre-pandemic prognostic scores seems to be a valid and rapid alternative to the need for developing new prognostic scores. Future research should focus on integrating these markers into existing pneumonia scores to improve their prognostic accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zinna</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0000-0001-2085</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Dentistry, Paediatrics, and Gynaecology, Division of Cardiac Surgery, University of Verona Medical School, 37129 Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pipitò</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1871-4285</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colomba</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3245-9396</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Disease Unit, "G. Di Cristina" Hospital, ARNAS Civico Di Cristina Benfratelli, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scichilone</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6400-6573</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licata</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0383-6121</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbagallo</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1349-6530</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4224-5343</Identifier><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppola</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5897-4949</Identifier><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cascio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1992-1796</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Tropical Disease Unit, AOU Policlinico "P. Giaccone", 90127 Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CRB-65</Keyword><Keyword MajorTopicYN="N">CZ COVID-19</Keyword><Keyword MajorTopicYN="N">PSI</Keyword><Keyword MajorTopicYN="N">PaO2/FiO2 ratio</Keyword><Keyword MajorTopicYN="N">SpO2</Keyword><Keyword MajorTopicYN="N">SpO2/FiO2 ratio</Keyword><Keyword MajorTopicYN="N">prognostic score</Keyword><Keyword MajorTopicYN="N">risk score</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407943</ArticleId><ArticleId IdType="pmc">PMC11478206</ArticleId><ArticleId IdType="doi">10.3390/jcm13195884</ArticleId><ArticleId IdType="pii">jcm13195884</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Satici M.O., Islam M.M., Satici C., Uygun C.N., Ademoglu E., Altunok İ., Aksel G., Eroglu S.E. The role of a noninvasive index ‘SpO2/FiO2’ in predicting mortality among patients with COVID-19 pneumonia. Am. J. Emerg. Med. 2022;57:54–59. doi: 10.1016/j.ajem.2022.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.04.036</ArticleId><ArticleId IdType="pmc">PMC9044731</ArticleId><ArticleId IdType="pubmed">35525158</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate S.M., Ahmed Ali S., Mantfardo B., Basu B. Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis. PLoS ONE. 2020;15:e0235653. doi: 10.1371/journal.pone.0235653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0235653</ArticleId><ArticleId IdType="pmc">PMC7351172</ArticleId><ArticleId IdType="pubmed">32649661</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight S.R., Ho A., Pius R., Buchan I., Carson G., Drake T.M., Dunning J., Fairfield C.J., Gamble C., Green C.A., et al. Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi: 10.1136/bmj.m3339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3339</ArticleId><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes E.K., Zambrano L.D., Anderson K.N., Marder E.P., Raz K.M., El Burai Felix S., Tie Y., Fullerton K.E. Coronavirus Disease 2019 Case Surveillance-United States, January 22–May 30, 2020. Morb. Mortal Wkly. Rep. 2020;69:759–765. doi: 10.15585/mmwr.mm6924e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6924e2</ArticleId><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Satici C., Demirkol M.A., Sargin Altunok E., Gursoy B., Alkan M., Kamat S., Demirok B., Surmeli C.D., Calik M., Cavus Z., et al. Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19. Int. J. Infect. Dis. 2020;98:84–89. doi: 10.1016/j.ijid.2020.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.038</ArticleId><ArticleId IdType="pmc">PMC7293841</ArticleId><ArticleId IdType="pubmed">32553714</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Tu G.W., Ju M.J., Yu S.J., Zheng J.L., Ma G.G., Liu K., Ma J.F., Yu K.H., Xue Y., et al. Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19. J. Infect. 2020;81:647–679. doi: 10.1016/j.jinf.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7204730</ArticleId><ArticleId IdType="pubmed">32389785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wibisono E., Hadi U., Bramantono, Arfijanto M.V., Rusli M., Rahman B.E., Asmarawati T.P., Choirunnisa M.L., Rahayu D.R.P. National early warning score (NEWS) 2 predicts hospital mortality from COVID-19 patients. Ann. Med. Surg. 2022;76:103462. doi: 10.1016/j.amsu.2022.103462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103462</ArticleId><ArticleId IdType="pmc">PMC8902861</ArticleId><ArticleId IdType="pubmed">35284070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Aggarwal R., Khanna P., Kumar R., Singh A.K., Soni K.D., Trikha A. Correlation of the SpO2/FiO2 (S/F) ratio and the PaO2/FiO2 (P/F) ratio in patients with COVID-19 pneumonia. Med. Intensiv. (Engl. Ed.) 2022;46:408–410. doi: 10.1016/j.medin.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC9221934</ArticleId><ArticleId IdType="pubmed">35753711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice T.W., Wheeler A.P., Bernard G.R., Hayden D.L., Schoenfeld D.A., Ware L.B., National Institutes of Health, National Heart, Lung. Blood Institute ARDS Network Comparison of the SpO2/FiO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132:410–417. doi: 10.1378/chest.07-0617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-0617</ArticleId><ArticleId IdType="pubmed">17573487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilan N., Dastranji A., Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J. Cardiovasc. Thorac. Res. 2015;7:28–31. doi: 10.15171/jcvtr.2014.06.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/jcvtr.2014.06</ArticleId><ArticleId IdType="pmc">PMC4378672</ArticleId><ArticleId IdType="pubmed">25859313</ArticleId></ArticleIdList></Reference><Reference><Citation>Festic E., Bansal V., Kor D.J., Gajic O. U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS). SpO2/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk. J. Intensive Care Med. 2015;30:209–216. doi: 10.1177/0885066613516411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066613516411</ArticleId><ArticleId IdType="pubmed">24362445</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho E.B., Leite T.R.S., Sacramento R.F.M., Nascimento P.R.L.D., Samary C.D.S., Rocco P.R.M., Silva P.L. Rationale and limitations of the SpO2/FiO2 as a possible substitute for PaO2/FiO2 in different preclinical and clinical scenarios. Rev. Bras. Ter. Intensiv. 2022;34:185–196. doi: 10.5935/0103-507X.20220013-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0103-507X.20220013-en</ArticleId><ArticleId IdType="pmc">PMC9345592</ArticleId><ArticleId IdType="pubmed">35674526</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcolino M.S., Pires M.C., Ramos L.E.F., Silva R.T., Oliveira L.M., Carvalho R.L.R., Mourato R.L.S., Sánchez-Montalvá A., Raventós B., Anschau F., et al. ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: Development, external validation and comparison with other available scores. Int. J. Infect. Dis. 2021;110:281–308. doi: 10.1016/j.ijid.2021.07.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.049</ArticleId><ArticleId IdType="pmc">PMC8302820</ArticleId><ArticleId IdType="pubmed">34311100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini C.C.R., Delfino-Pereira P., Pires M.C., Ramos L.E.F., Gomes A.G.D.R., Jorge A.O., Fagundes A.L., Garcia B.M., Pessoa B.P., de Carvalho C.A., et al. Assessment of the ABC2-SPH risk score to predict invasive mechanical ventilation in COVID-19 patients and comparison to other scores. Front. Med. 2023;10:1259055. doi: 10.3389/fmed.2023.1259055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1259055</ArticleId><ArticleId IdType="pmc">PMC10690599</ArticleId><ArticleId IdType="pubmed">38046414</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C., Rozzini R., Vannini M., Coccia F., Cesaroni G., Mazzeo F., Cola M., Bartoloni A., Fontanari P., Lavorini F., et al. Clinical risk score to predict in-hospital mortality in COVID-19 patients: A retrospective cohort study. BMJ Open. 2020;10:e040729. doi: 10.1136/bmjopen-2020-040729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040729</ArticleId><ArticleId IdType="pmc">PMC7520809</ArticleId><ArticleId IdType="pubmed">32978207</ArticleId></ArticleIdList></Reference><Reference><Citation>Trongtrakul K., Tajarernmuang P., Limsukon A., Theerakittikul T., Niyatiwatchanchai N., Surasit K., Glunriangsang P., Liwsrisakun C., Bumroongkit C., Pothirat C., et al. The National Early Warning Score 2 with Age and Body Mass Index (NEWS2 Plus) to Determine Patients with Severe COVID-19 Pneumonia. J. Clin. Med. 2024;13:298. doi: 10.3390/jcm13010298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13010298</ArticleId><ArticleId IdType="pmc">PMC10780151</ArticleId><ArticleId IdType="pubmed">38202305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinna G., Pipitò L., Colomba C., Scichilone N., Licata A., Barbagallo M., Russo A., Almasio P.L., Coppola N., Cascio A. The Development and Validation of a New Mortality Risk Score. J. Clin. Med. 2024;13:1832. doi: 10.3390/jcm13071832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13071832</ArticleId><ArticleId IdType="pmc">PMC11012743</ArticleId><ArticleId IdType="pubmed">38610597</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen D.M., Strange J.E., Gislason G., Torp-Pedersen C., Gerds T., Fosbøl E., Phelps M. Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients. J. Gen. Intern. Med. 2020;35:2801–2803. doi: 10.1007/s11606-020-05991-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05991-z</ArticleId><ArticleId IdType="pmc">PMC7314426</ArticleId><ArticleId IdType="pubmed">32583345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega L., Sierra M., Domínguez J., Martínez J., Matas L., Bastart F., Galí N., Ausina V. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia. Scand. J. Infect. Dis. 2005;37:657–663. doi: 10.1080/00365540510027174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365540510027174</ArticleId><ArticleId IdType="pubmed">16126566</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller K., Schmitt V.H., Sagoschen I., Münzel T., Espinola-Klein C., Hobohm L. CRB-65 for Risk Stratification and Prediction of Prognosis in Pulmonary Embolism. J. Clin. Med. 2023;12:1264. doi: 10.3390/jcm12041264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041264</ArticleId><ArticleId IdType="pmc">PMC9961795</ArticleId><ArticleId IdType="pubmed">36835800</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally M., Curtain J., O’Brien K.K., Dimitrov B.D., Fahey T. Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: Systematic review and meta-analysis. Br. J. Gen. Pract. 2010;60:e42. doi: 10.3399/bjgp10X532422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp10X532422</ArticleId><ArticleId IdType="pmc">PMC2944951</ArticleId><ArticleId IdType="pubmed">20883616</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G.B., Redfern O.C., Pimentel M.A., Gerry S., Collins G.S., Malycha J., Prytherch D., Schmidt P.E., Watkinson P.J. The National Early Warning Score 2 (NEWS2) Clin. Med. 2019;19:260. doi: 10.7861/clinmedicine.19-3-260.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.19-3-260</ArticleId><ArticleId IdType="pmc">PMC6542226</ArticleId><ArticleId IdType="pubmed">31092526</ArticleId></ArticleIdList></Reference><Reference><Citation>Crocker-Buque T., Myles J., Brentnall A., Gabe R., Duffy S., Williams S., Tiberi S. Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission. PLoS ONE. 2022;17:e0274158. doi: 10.1371/journal.pone.0274158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274158</ArticleId><ArticleId IdType="pmc">PMC9555674</ArticleId><ArticleId IdType="pubmed">36223373</ArticleId></ArticleIdList></Reference><Reference><Citation>Douillet D., Riou J., Morin F., Mahieu R., Chauvin A., Gennai S., Ferrant L., Lopez R., Sebbane M., Plantefeve G., et al. Derivation and validation of a risk-stratification model for patients with probable or proven COVID-19 in EDs: The revised HOME-CoV score. Emerg. Med. J. 2024;41:218–225. doi: 10.1136/emermed-2022-212631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2022-212631</ArticleId><ArticleId IdType="pubmed">38365436</ArticleId></ArticleIdList></Reference><Reference><Citation>Werfel S., Jakob C.E.M., Borgmann S., Schneider J., Spinner C., Schons M., Hower M., Wille K., Haselberger M., Heuzeroth H., et al. Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients. J. Med. Virol. 2021;93:6703–6713. doi: 10.1002/jmv.27252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27252</ArticleId><ArticleId IdType="pmc">PMC8426905</ArticleId><ArticleId IdType="pubmed">34331717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua F., Vancheeswaran R., Draper A., Vaghela T., Knight M., Mogal R., Singh J., Spencer L.G., Thwaite E., Mitchell H., et al. Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score. Thorax. 2021;76:696–703. doi: 10.1136/thoraxjnl-2020-216425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216425</ArticleId><ArticleId IdType="pubmed">33692174</ArticleId></ArticleIdList></Reference><Reference><Citation>Huespe I., Carboni Bisso I., Di Stefano S., Terrasa S., Gemelli N.A., Las Heras M. COVID-19 Severity Index: A predictive score for hospitalized patients. Med. Intensiv. (Engl. Ed.) 2022;46:98–101. doi: 10.1016/j.medin.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC8629742</ArticleId><ArticleId IdType="pubmed">34896032</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotto R., Lanzardo A., Buonomo A.R., Pinchera B., Cattaneo L., Sardanelli A., Mercinelli S., Viceconte G., Perrella A., Esposito V., et al. A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19. Vaccines. 2022;10:2043. doi: 10.3390/vaccines10122043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10122043</ArticleId><ArticleId IdType="pmc">PMC9781962</ArticleId><ArticleId IdType="pubmed">36560453</ArticleId></ArticleIdList></Reference><Reference><Citation>Klén R., Huespe I.A., Gregalio F.A., Lalueza Blanco A.L., Pedrera Jimenez M., Garcia Barrio N., Valdez P.R., Mirofsky M.A., Boietti B., Gómez-Huelgas R., et al. Development and validation of COEWS (COVID-19 Early Warning Score) for hospitalized COVID-19 with laboratory features: A multicontinental retrospective study. Elife. 2023;12:e85618. doi: 10.7554/eLife.85618.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.85618</ArticleId><ArticleId IdType="pmc">PMC10479961</ArticleId><ArticleId IdType="pubmed">37615346</ArticleId></ArticleIdList></Reference><Reference><Citation>Catoire P., Tellier E., de la Rivière C., Beauvieux M.C., Valdenaire G., Galinski M., Revel P., Combes X., Gil-Jardiné C. Assessment of the SpO2/FiO2 ratio as a tool for hypoxemia screening in the emergency department. Am. J. Emerg. Med. 2021;44:116–120. doi: 10.1016/j.ajem.2021.01.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.01.092</ArticleId><ArticleId IdType="pmc">PMC7865090</ArticleId><ArticleId IdType="pubmed">33588251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pripp A.H. Pearsons eller Spearmans korrelasjonskoeffisienter [Pearson’s or Spearman’s correlation coefficients] Tidsskr Nor Laegeforen. 2018;138 doi: 10.4045/tidsskr.18.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.18.0042</ArticleId><ArticleId IdType="pubmed">29737766</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44:837–845. doi: 10.2307/2531595.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531595</ArticleId><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich J.T., Neely J.G., Paniello R.C., Voelker C.C., Nussenbaum B., Wang E.W. A practical guide to understanding Kaplan-Meier curves. Otolaryngol. Head. Neck Surg. 2010;143:331–336. doi: 10.1016/j.otohns.2010.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2010.05.007</ArticleId><ArticleId IdType="pmc">PMC3932959</ArticleId><ArticleId IdType="pubmed">20723767</ArticleId></ArticleIdList></Reference><Reference><Citation>Haileamlak A. The impact of COVID-19 on health and health systems. Ethiop. J. Health Sci. 2021;31:1073–1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968362</ArticleId><ArticleId IdType="pubmed">35392335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh Hosseingholi E., Maddahi S., Jabbari S., Molavi G. Identification of High Death Risk Coronavirus Disease-19 Patients using Blood Tests. Adv. Biomed. Res. 2022;11:58. doi: 10.4103/abr.abr_178_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/abr.abr_178_21</ArticleId><ArticleId IdType="pmc">PMC9482375</ArticleId><ArticleId IdType="pubmed">36124024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson P.G., Qin L., Puah S.H. COVID-19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical pre-COVID-19 ARDS. Med. J. Aust. 2020;213:54–56.e1. doi: 10.5694/mja2.50674.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50674</ArticleId><ArticleId IdType="pmc">PMC7361309</ArticleId><ArticleId IdType="pubmed">32572965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodai L., Saghaei M., Habibzadeh M., Alikiaii B., Hashemi S.J. Estimating the best fraction of inspired oxygen for calculation of PaO2/FiO2 ratio in acute respiratory distress syndrome due to COVID-19 pneumonia. J. Res. Med. Sci. 2022;27:38. doi: 10.4103/jrms.jrms_558_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jrms.jrms_558_21</ArticleId><ArticleId IdType="pmc">PMC9374145</ArticleId><ArticleId IdType="pubmed">35968211</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartini S., Massobrio L., Cutuli O., Campodonico P., Bernini C., Sartini M., Cristina M.L., Castellani L., Ceschi L., Spadaro M., et al. Role of SatO2, PaO2/FiO2 Ratio and PaO2 to Predict Adverse Outcome in COVID-19: A Retrospective, Cohort Study. Int. J. Environ. Res. Public Health. 2021;18:11534. doi: 10.3390/ijerph182111534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182111534</ArticleId><ArticleId IdType="pmc">PMC8582831</ArticleId><ArticleId IdType="pubmed">34770046</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberdi-Iglesias A., Martín-Rodríguez F., Ortega Rabbione G., Rubio-Babiano A.I., Núñez-Toste M.G., Sanz-García A., Del Pozo Vegas C., Castro Villamor M.A., Martín-Conty J.L., Jorge-Soto C., et al. Role of SpO2/FiO2 Ratio and ROX Index in Predicting Early Invasive Mechanical Ventilation in COVID-19. A Pragmatic, Retrospective, Multi-Center Study. Biomedicines. 2021;9:1036. doi: 10.3390/biomedicines9081036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9081036</ArticleId><ArticleId IdType="pmc">PMC8392288</ArticleId><ArticleId IdType="pubmed">34440240</ArticleId></ArticleIdList></Reference><Reference><Citation>Roozeman J.P., Mazzinari G., Serpa Neto A., Hollmann M.W., Paulus F., Schultz M.J., Pisani L., PRoVENT-COVID Collaborative Group Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19-Insights from the PRoVENT-COVID study. J. Crit. Care. 2022;68:31–37. doi: 10.1016/j.jcrc.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8641962</ArticleId><ArticleId IdType="pubmed">34872014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Jiang L., Chen T., Wang Y., Zhang B., Hong Y., Wang J., Yan F. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir. Res. 2020;21:194. doi: 10.1186/s12931-020-01455-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01455-4</ArticleId><ArticleId IdType="pmc">PMC7374662</ArticleId><ArticleId IdType="pubmed">32698822</ArticleId></ArticleIdList></Reference><Reference><Citation>García Clemente M.M., Herrero Huertas J., Fernández Fernández A., De La Escosura Muñoz C., Enríquez Rodríguez A.I., Pérez Martínez L., Gómez Mañas S., Iscar Urrutia M., López González F.J., Madrid Carbajal C.J., et al. Assessment of risk scores in COVID-19. Int. J. Clin. Pract. 2021;75:e13705. doi: 10.1111/ijcp.13705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13705</ArticleId><ArticleId IdType="pubmed">32931634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J.D., Singanayagam A., Akram A.R., Mandal P., Short P.M., Choudhury G., Wood V., Hill A.T. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax. 2010;65:878–883. doi: 10.1136/thx.2009.133280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.133280</ArticleId><ArticleId IdType="pubmed">20729231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki H.A., Hamdi Alkahlout B., Shaban E., Mohamed E.H., Basharat K., Elsayed W.A.E., Azad A. The Battle of the Pneumonia Predictors: A Comprehensive Meta-Analysis Comparing the Pneumonia Severity Index (PSI) and the CURB-65 Score in Predicting Mortality and the Need for ICU Support. Cureus. 2023;15:e42672. doi: 10.7759/cureus.42672.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.42672</ArticleId><ArticleId IdType="pmc">PMC10462911</ArticleId><ArticleId IdType="pubmed">37649936</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana A.R., Amorim F.F., Soares F.B., de Souza Godoy L.G., de Jesus Almeida L., Rodrigues T.A., de Andrade Filho G.M., Silva T.A., da Silva Neto O.G., Rocha P.H.G., et al. Comparison of CURB-65 and CRB-65 as predictors of death in community-acquired pneumonia in adults admitted to an ICU. Crit. Care. 2013;17((Suppl. 3)):P39. doi: 10.1186/cc12655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebell M.H., Walsh M.E., Fahey T., Kearney M., Marchello C. Meta-analysis of Calibration, Discrimination, and Stratum-Specific Likelihood Ratios for the CRB-65 Score. J. Gen. Intern. Med. 2019;34:1304–1313. doi: 10.1007/s11606-019-04869-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-019-04869-z</ArticleId><ArticleId IdType="pmc">PMC6614215</ArticleId><ArticleId IdType="pubmed">30993633</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan G., Tu C., Zhou F., Liu Z., Wang Y., Song B., Gu X., Wang Y., Wei Y., Li H., et al. Comparison of severity scores for COVID-19 patients with pneumonia: A retrospective study. Eur. Respir. J. 2020;56:2002113. doi: 10.1183/13993003.02113-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02113-2020</ArticleId><ArticleId IdType="pmc">PMC7366179</ArticleId><ArticleId IdType="pubmed">32675205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V., Aleem A., Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. StatPearls Publishing; Treasure Island, FL, USA: 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Liang H., Ou L., Chen B., Chen A., Li C., Li Y., Guan W., Sang L., Lu J., et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern. Med. 2020;180:1081–1089. doi: 10.1001/jamainternmed.2020.2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.2033</ArticleId><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Doğanay F., Ak R. Performance of the CURB-65, ISARIC-4C and COVID-GRAM scores in terms of severity for COVID-19 patients. Int. J. Clin. Pract. 2021;75:e14759. doi: 10.1111/ijcp.14759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14759</ArticleId><ArticleId IdType="pmc">PMC8646358</ArticleId><ArticleId IdType="pubmed">34455674</ArticleId></ArticleIdList></Reference><Reference><Citation>Albahri A.S., Hamid R.A., Alwan J.K., Al-Qays Z.T., Zaidan A.A., Zaidan B.B., Albahri A.O.S., AlAmoodi A.H., Khlaf J.M., Almahdi E.M., et al. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. J. Med. Syst. 2020;44:122. doi: 10.1007/s10916-020-01582-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-020-01582-x</ArticleId><ArticleId IdType="pmc">PMC7247866</ArticleId><ArticleId IdType="pubmed">32451808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R.K., Harrison E.M., Ho A., Docherty A.B., Knight S.R., van Smeden M., Abubakar I., Lipman M., Quartagno M., Pius R., et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: A prospective cohort study. Lancet Respir. Med. 2021;9:349–359. doi: 10.1016/S2213-2600(20)30559-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30559-2</ArticleId><ArticleId IdType="pmc">PMC7832571</ArticleId><ArticleId IdType="pubmed">33444539</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwazzeh M.J., Subbarayalu A.V., Abu Ali B.M., Alabdulqader R., Alhajri M., Alwarthan S.M., AlShehail B.M., Raman V., Almuhanna F.A. Performance of CURB-65 and ISARIC 4C mortality scores for hospitalized patients with confirmed COVID-19 infection in Saudi Arabia. Inform. Med. Unlocked. 2023;39:101269. doi: 10.1016/j.imu.2023.101269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2023.101269</ArticleId><ArticleId IdType="pmc">PMC10167802</ArticleId><ArticleId IdType="pubmed">37193544</ArticleId></ArticleIdList></Reference><Reference><Citation>Leening M.J., Vedder M.M., Witteman J.C., Pencina M.J., Steyerberg E.W. Net reclassification improvement: Computation, interpretation, and controversies: A literature review and clinician’s guide. Ann. Intern. Med. 2014;160:122–131. doi: 10.7326/M13-1522.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M13-1522</ArticleId><ArticleId IdType="pubmed">24592497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr K.F., Wang Z., Janes H., McClelland R.L., Psaty B.M., Pepe M.S. Net reclassification indices for evaluating risk prediction instruments: A critical review. Epidemiology. 2014;25:114–121. doi: 10.1097/EDE.0000000000000018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000018</ArticleId><ArticleId IdType="pmc">PMC3918180</ArticleId><ArticleId IdType="pubmed">24240655</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunkemeier G.L., Jin R. Net reclassification index: Measuring the incremental value of adding a new risk factor to an existing risk model. Ann. Thorac. Surg. 2015;99:388–392. doi: 10.1016/j.athoracsur.2014.10.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.10.084</ArticleId><ArticleId IdType="pubmed">25639389</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>